Timing
Purchase and sale flow
PurchasesSales
Stock, pipeline and biotech catalyst intelligence
Reported ownership activity
Activity signal
No open-market purchases versus $8.3M in reported salesOption exercises, awards, and grants are separated from open-market direction.Timing
Composition
Concentration
| Insider trading | Relationship | Date | Transaction | Cost | Shares | Value | Shares total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Yeganeh Reuven | Director | Mar 17 '26 | Sale | $5.00 | 530,000 | $2,650,000 | 0 | Mar 18 05:47 PM |
| Yeganeh Reuven | Director | Mar 16 '26 | Sale | $5.00 | 450,000 | $2,250,000 | 0 | Mar 18 05:47 PM |
Company profile
BiomX Inc., a holding company, focuses on defense, security, and critical infrastructure technologies. The company's portfolio targets various niches, such as counter-drone systems, AI-enabled command-and-control, perimeter and border security, wide-area surveillance, and aerial firefighting. It serves defense agencies, prime contractors, transportation operators, municipalities, and critical infrastructure providers. The company was founded in 2015 and is based in Dover, Delaware.
Company profile supplied by Yahoo Finance. Catalyst dates can change and should be confirmed against the linked primary source.
Page updated Aug 21, 2026 · Yahoo quotes cached for one minute; reference data may be used when a live field is unavailable.
| Yeganeh Reuven | Director | Mar 13 '26 | Sale | $5.00 | 370,000 | $1,850,000 | 0 | Mar 13 04:30 PM |
Transactions may include sales, purchases, grants, and option exercises. Directional charts count only purchases and sales; follow the Form 4 link to verify the original SEC filing.